Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **CD3 antigen complex** is a multimeric protein assembly found exclusively on the surface of mature **T lymphocytes**. It consists of four distinct polypeptide chains—CD3γ, CD3δ, two copies of CD3ε—and usually associates with a homodimeric zeta chain (CD247), forming three pairs of dimers within the larger **T-cell receptor–CD3 (TCR–CD3) signaling apparatus**. The primary function is as a signal-transducing module for the antigen-specific αβ or γδ **T-cell receptor**, which itself lacks intrinsic signaling capacity. Upon engagement by peptide-MHC complexes presented by antigen-presenting cells, conformational changes and phosphorylation events within conserved intracellular ITAM motifs on each chain initiate downstream signaling cascades that drive **T-cell activation**, proliferation, cytokine production, and effector functions essential for adaptive immunity. The presence and integrity of all subunits are required for proper assembly at the plasma membrane; loss or mutation leads to severe immunodeficiency due to failed surface expression and function. The unique expression pattern makes it an ideal pan-T cell marker in diagnostics as well as a key therapeutic target—most notably exploited by monoclonal antibodies such as muromonab-CD3 for transplant rejection prevention and bispecific antibody constructs like blinatumomab in oncology. Therapeutic manipulation carries significant risks including cytokine release syndrome from rapid systemic immune activation. Research continues into more selective targeting strategies leveraging its central role in adaptive immunity.[1][4][5][6]
Antibody-mediated modulation or depletion of T cells via binding to CD3ε subunit, leading to immune activation or suppression depending on context
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD3 antigen complex (CD3).